correspondent-denominate
Living With Myelofibrosis

Monthly Archives: May 2010

YM BioSciences announces early expansion of ongoing CYT387 Phase I/II clinical study based on favorable safety and activity data

Press Release Source: YM BioSciences Inc. On Tuesday March 30, 2010, 7:30 am EDT

MISSISSAUGA, ON, March 30 /PRNewswire-FirstCall/ – YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients… Continue reading

Translate This Page
Who's Online
2 visitors online now
Follow Us

Copyright © 2011. All Rights Reserved.